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Abstract. 
 
We recently isolated a novel actin ﬁlament 
(F-actin)–binding protein, afadin, that has two iso-
forms, l- and s-afadins. l-Afadin is ubiquitously ex-
pressed and speciﬁcally localized at zonula adherens 
(ZA) in epithelial cells and at cell–cell adherens junc-
tion (AJ) in nonepithelial cells, whereas s-afadin is 
abundantly expressed in neural tissue. l-Afadin has
one PDZ domain, three proline-rich regions, and one 
F-actin–binding domain, whereas s-afadin lacks the 
third proline-rich region and the F-actin–binding do-
main. To understand the molecular mechanism of the 
speciﬁc localization of l-afadin at ZA in epithelial cells 
and at cell–cell AJ in nonepithelial cells, we attempted 
here to identify an l-afadin–binding protein(s) and iso-
lated a protein, named ponsin. Ponsin had many splic-
ing variants and the primary structures of two of them 
were determined. Both the two variants had three Src 
homology 3 (SH3) domains and turned out to be splic-
ing variants of SH3P12. The third proline-rich region of 
l-afadin bound to the region of ponsin containing the 
second and third SH3 domains. Ponsin was ubiquitously 
expressed and localized at ZA in epithelial cells, at
cell–cell AJ in nonepithelial cells, and at cell–matrix AJ 
 
in both types of cells. Ponsin furthermore directly bound 
vinculin, an F-actin–binding protein localized at ZA in 
epithelial cells, at cell–cell AJ in nonepithelial cells, and 
at cell–matrix AJ in both types of cells. Vinculin has one 
proline-rich region where two proline-rich sequences 
are located. The proline-rich region bound to the region 
of ponsin containing the ﬁrst and second SH3 domains. 
l-Afadin and vinculin bound to ponsin in a competitive 
manner and these three proteins hardly formed a ter-
nary complex. These results indicate that ponsin is an
l-afadin– and vinculin-binding protein localized at ZA 
in epithelial cells, at cell–cell AJ in nonepithelial cells, 
and at cell–matrix AJ in both types of cells.
Key words: ponsin • l-afadin • vinculin • zonula adhe-
rens • cell–matrix adherens junction
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HE
 
 cell junction plays essential roles in various cell
functions, including cell adhesion, growth, polariza-
tion, and motility (Takeichi, 1988, 1991; Luna and
Hitt, 1992; Jockusch et al., 1995; Gumbiner, 1996). The cell
junction is classified into two types: cell–cell and cell–matrix
junctions. In polarized epithelial cells, the cell–cell junc-
tion shows a specialized membrane structure, comprised
of zonula occludens (ZO
 
1
 
, tight junction), zonula adherens
(ZA), and desmosome, which is known as the junctional
complex. These three junctional structures are typically
aligned from the apical to the basal side of the lateral
membrane, although desmosome is independently distrib-
uted in other areas.
At ZA, cadherins interact with each other at the extra-
cellular surface and serve as a critical adhesion molecule
(Takeichi, 1988, 1991; Geiger and Ginsberg, 1991; Tsukita
et al., 1992). The cytoplasmic region of cadherin interacts
with 
 
b
 
- and 
 
g
 
-catenins, and 
 
b
 
-catenin binds 
 
a
 
-catenin
(Ozawa et al., 1989; Nagafuchi et al., 1991; Takeichi, 1991;
Tsukita et al., 1992; Aberle et al., 1994). 
 
a
 
-Catenin inter-
acts directly with actin filament (F-actin) or indirectly with
it through 
 
a
 
-actinin and vinculin, other F-actin–binding
proteins (Knudsen et al., 1995; Rimm et al., 1995; Weiss et al.,
1998; Watabe-Uchida et al., 1998). ZA is distinguished
from cadherin-based cell–cell adherens junction (AJ) in
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nonepithelial cells by having a thick F-actin belt, called the
circumferential filament band. Furthermore, while ZA is
defined as a junctional structure observed by electron mi-
croscopy, the cadherin-catenin system is not confined to
ZA, but distributed along the entire lateral membrane
(Tsukita et al., 1992; Gumbiner, 1996). 
 
a
 
-Actinin is also
broadly distributed (Geiger et al., 1981). In this study,
therefore, we use “cell–cell AJ” as cell–cell adhesion site
where cadherin is present, and distinguish “cell–cell AJ”
from “ZA.” In contrast, vinculin is more highly concen-
trated at ZA than the cadherin-catenin system (Geiger et al.,
1981; Yonemura et al., 1995).
The cell–matrix junction is comprised of cell–matrix AJ
and hemidesmosome. At cell–matrix AJ where integrin in-
teracts with matrix proteins at the extracellular surface,
the cytoplasmic region of integrin 
 
b
 
 subunit directly binds
talin (Horwitz et al., 1986) and 
 
a
 
-actinin (Otey et al.,
1990), both of which directly interact with F-actin. Fur-
thermore, talin directly binds vinculin (Burridge and Man-
geat, 1984). We have recently shown that a novel F-actin–
binding protein, named nexilin, is localized at cell–matrix
AJ (Ohtsuka et al., 1998).
Thus, many F-actin–binding proteins serve as linkers of
the actin cytoskeleton to the adhesion molecules, such as
cadherin and integrin. However, little is known about the
mechanism of how these F-actin–binding proteins are in-
volved in the establishment of the polarized junctional
alignment in epithelial cells. It has neither fully been un-
derstood how these F-actin–binding proteins regulate the
function of the adhesion molecules nor how the adhesion
molecule-initiated signals are transduced to the F-actin–
binding proteins.
We have recently isolated a novel cell–cell AJ com-
ponent, named l-afadin, as an F-actin–binding protein
(Mandai et al., 1997). l-Afadin has a small splicing vari-
ant, named s-afadin. l-Afadin is ubiquitously expressed,
whereas s-afadin is abundantly expressed in neural tissue.
l-Afadin has one PDZ domain at the middle region, three
proline-rich regions following the PDZ domain, and one
F-actin–binding domain at the COOH-terminal region.
s-Afadin has one PDZ domain but lacks the third proline-
rich region and the F-actin–binding domain. s-Afadin is
the protein encoded by the 
 
AF-6
 
 gene, which is originally
found to be fused to the 
 
ALL-1
 
 gene (Prasad et al., 1993),
known to be involved in acute leukemia (Cimino et al.,
1991). Immunofluorescence and immunoelectron micro-
scopic analyses indicate that l-afadin is localized at ZA in
small intestine absorptive epithelial cells and at cell–cell
AJ in nonepithelial cells, such as intercalated disc in car-
diac muscle cells (Mandai et al., 1997). In contrast to our
results, another group has reported that the AF-6 protein
(s-afadin) is localized at ZO in Madin-Darby canine kid-
ney (MDCK) cells (Yamamoto et al., 1997). Recently,
consistent with our previous results (Mandai et al., 1997),
we have found that l-afadin is a major expressed variant
and is localized at the junctional complex region in MDCK
cells (Sakisaka et al., 1999). However, it is difficult to con-
clude that l-afadin is localized at ZO or ZA in MDCK cells
because ZO and ZA are not well separated in this cell line.
Furthermore, l-afadin does not directly bind to 
 
a
 
-, 
 
b
 
-cate-
nin, or the cytoplasmic region of E-cadherin (Sakisaka et al.,
1999).
 
The results thus far available suggest that there is a
mechanism that determines the specific localization of
l-afadin at ZA in epithelial cells and at cell–cell AJ in non-
epithelial cells. To understand the molecular mechanism
of this specific localization of l-afadin, we attempted here
to identify an l-afadin–binding protein(s) specifically local-
ized at these sites, and isolated a protein. The isolated pro-
tein had many splicing variants and the primary structures
of two of them were determined. They turned out to be
splicing variants of SH3P12, which had originally been
identified as a Src homology 3 (SH3) domain-containing
protein (Sparks et al., 1996). The l-afadin–binding protein
isolated here as well as SH3P12 had three SH3 domains at
their COOH-terminal regions and two sorbin-like regions
at their NH
 
2
 
-terminal regions. SH3 domains have first
been identified as conserved, noncatalytic regions in cyto-
plasmic tyrosine kinases such as Src (Cohen et al., 1995;
Pawson, 1995) and subsequently shown to interact with
proline-rich sequences (Yu et al., 1994). Sorbin is a pep-
tide hormone that induces the absorption of water and so-
dium in upper small intestine (Pansu et al., 1981). Further-
more, we have found that the l-afadin–binding protein
directly bound vinculin, an F-actin–binding protein (Joc-
kusch et al., 1995) that is localized at ZA in epithelial cells,
at cell–cell AJ in nonepithelial cells (Weiss et al., 1998;
Watabe-Uchida et al., 1998), and at cell–matrix AJ in both
types of cells (Burridge and Mangeat, 1984). The l-afadin–
binding protein was also colocalized with vinculin at these
sites. We named this protein ponsin (from the Latin word
pons, meaning a bridge) because it was capable of binding
both l-afadin and vinculin. We describe here the purifica-
tion and characterization of ponsin.
 
Materials and Methods
 
Blot Overlay
 
Blot overlay was done using 
 
35
 
S-labeled l-afadin, ponsin, or vinculin as de-
scribed (Shieh and Zhu, 1996; Chevesich et al., 1997), with a slight modifi-
cation. In brief, 
 
35
 
S-labeled l-afadin, ponsin, and vinculin were generated
with pBlue vectors containing full-length cDNAs of l-afadin, ponsin, and
vinculin, respectively, using the TNT T7 quick coupled transcription/
translation system (Promega Corp.). The vinculin cDNA (Watabe-Uchida
et al., 1998) was kindly supplied by Drs. Y. Imamura, A. Nagafuchi, and
Sh. Tsukita (Kyoto University, Kyoto, Japan). To remove free 
 
35
 
S-methi-
onine, each translated protein was applied to a Bio-Spin 6 chromatogra-
phy column (Bio-Rad Laboratories). Each eluate from the column was
used as a probe. The sample to be tested was subjected to SDS-PAGE and
transferred to a nitrocellulose membrane. The membrane was blocked in
PBS containing 5% defatted powder milk and 1% Triton X-100. The
membrane was then incubated at 4
 
8
 
C for 16 h with the 
 
35
 
S-labeled l-afa-
din, ponsin, or vinculin probe (
 
z
 
2 
 
3 
 
10
 
6
 
 cpm/ml each) in PBS containing
5% defatted powder milk and 1% Triton X-100. After the incubation, the
membrane was washed with PBS containing 5% defatted powder milk
and 1% Triton X-100, followed by autoradiography using an image ana-
lyzer (Fujix BAS-2000II; Fuji Photo Film Co.).
 
Purification of Ponsin
 
The AJ-enriched fraction was prepared from 80 rat livers as described
(Tsukita and Tsukita, 1989), and stored at 
 
2
 
80
 
8
 
C until use. Half of the AJ-
enriched fraction was dissolved in an extraction solution (20 mM Tris-HCl
at pH 9.0, 8 M urea, 1 mM DTT, and 1% hydrogenated Triton X-100; Cal-
biochem Corp.). After sonication, the solution was mildly stirred at room
temperature for 1 h and centrifuged at 100,000 
 
g
 
 at 20
 
8
 
C for 30 min. The
supernatant was diluted with a buffer (20 mM Tris-HCl at pH 9.0 and 1
mM DTT) to give final concentrations of 6 M urea and 0.75% hydroge- 
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nated Triton X-100. This sample (135 ml, 91 mg of protein) was applied to
a Mono Q HR 10/10 column (Amersham-Pharmacia Biotechnology)
equilibrated with buffer A (20 mM Tris-HCl at pH 9.0, 6 M urea, 0.75%
CHAPS, and 1 mM DTT). After the column was washed with 70 ml of
buffer A, elution was performed with a 160-ml linear gradient of sodium
chloride (0–0.3 M) in buffer A. Fractions of 1.5 ml each were collected.
When each fraction was subjected to 
 
35
 
S-labeled l-afadin blot overlay, the
radioactive bands appeared in fractions 14–25. These active fractions (18
ml, 3.1 mg of protein) were collected. The other half of the AJ-enriched
fraction was also subjected to the Mono Q column chromatography in the
same manner as described above. The active fractions of the two Mono Q
column chromatographies were combined. The combined sample was ap-
plied to a hydroxyapatite column (0.75 
 
3 
 
7.5 cm; Tosoh) equilibrated with
buffer B (8 mM potassium phosphate at pH 7.8, 6 M urea, 0.75% CHAPS,
and 1 mM DTT). After the column was washed with 15 ml of the same
buffer, elution was performed with a 25-ml linear gradient of potassium
phosphate (8–100 mM) at pH 7.8 in buffer B. Fractions of 0.5 ml each
were collected. When each fraction was subjected to 
 
35
 
S-labeled l-afadin
blot overlay, the radioactive bands appeared in fractions 25–33. The active
fractions (4.5 ml, 1 mg of protein) were collected and applied to a Mono S
PC 1.6/5 column (Amersham-Pharmacia Biotechnology) equilibrated with
buffer C (50 mM sodium acetate at pH 4.0, 6 M urea, 0.75% CHAPS, and
1 mM DTT). After the column was washed with 0.7 ml of buffer C con-
taining 0.15 M sodium chloride, elution was performed with a 2-ml linear
gradient of sodium chloride (0.15–0.4 M) in buffer C. Fractions of 0.1 ml
each were collected. When each fraction was subjected to 
 
35
 
S-labeled
l-afadin blot overlay, the radioactive bands appeared in fractions 9–13
(see Fig. 1). The active fractions were stored at 
 
2
 
80
 
8
 
C.
 
Peptide Microsequencing and Cloning of the
Ponsin cDNAs
 
On the Mono S column chromatography, three radioactive bands with
molecular masses of 
 
z
 
95 (p95), 93 (p93), and 70 (p70) kD were identified
by 
 
35
 
S-labeled l-afadin blot overlay (see Fig. 1). The purified Mono S sam-
ples, fraction 10 for p93 and p95, and fractions 12 and 13 for p70, were
subjected to SDS-PAGE (8% polyacrylamide gel). The protein bands cor-
responding to p95, p93, and p70 were separately cut out from the gel and
digested with a lysyl endopeptidase, and the digested peptides were sepa-
rated by TSKgel ODS-80Ts (4.6 
 
3 
 
150 mm; Tosoh) reverse phase HPLC
as described (Imazumi et al., 1994). The amino acid (aa) sequences of the
peptides were determined with a peptide sequencer. BLAST search of the
GenBank database indicated that these sequences were almost identical
to that of the mouse 
 
SH3P12
 
 gene product (U58883; GenBank/EMBL/
DDBJ). Based on the sequence of 
 
SH3P12
 
, oligonucleotide primers, 5
 
9
 
-
CATTGGAAGACCTTGAGATCC-3
 
9
 
 and 5
 
9
 
-GAATGATGCTTCAT-
CCTCCG-3
 
9
 
, were designed and a PCR reaction was performed using a
mouse brain cDNA (Clontech) as a template. DNA sequencing was per-
formed by the dideoxynucleotide termination method using a DNA se-
quencer (ABI 373).
 
Expression and Purification of Recombinant Proteins
 
Prokaryote and eukaryote expression vectors were constructed in pCMV5
(Satoh et al., 1998), pCMV-Myc (Mandai et al., 1997), pFLAG-CMV2
(Eastman Kodak Scientific Imaging Systems), pGEX (Amersham-Phar-
macia Biotechnology), pMal-C2 (New England Biolabs Inc.), and pQE
(QIAGEN Inc.) using standard molecular biology methods (Sambrook
et al., 1989). pCMV-Myc and pFLAG-CMV2 were designed to express
the proteins with the NH
 
2
 
-terminal Myc- and FLAG-epitopes, respec-
tively. Various eukaryote expression constructs contained the following aa
residues: pCMV5–l-afadin, 1–1829 (the full length); pCMV5–s-afadin,
1–1663 (the full length); pCMV-Myc–l-afadin, 1–1829 (the full length);
pCMV-Myc–s-afadin, 1–1663 (the full length); pCMV-Myc–ponsin-1,
1–714 (the full length); pCMV-Myc–ponsin-2, 1–724 (the full length);
pCMV-Myc–vinculin-N, 1–533 (the NH
 
2
 
-terminal half); pCMV-Myc–vin-
culin-C, 534–1066 (the COOH-terminal half); pCMV-Myc–vinculin-1, 1–800
(the NH
 
2
 
-terminal region); pCMV-Myc–vinculin-2, 801–1066 (the COOH-
terminal region); pFLAG-CMV2–ponsin-1, 1–714 (the full length); and
pFLAG-CMV2–ponsin-2, 1–724 (the full length). These constructs were
transfected to COS7 cells with a DEAE-dextran method (Hata and Süd-
hof, 1995). The Myc-tagged recombinant proteins were purified from the
cell extracts by immunoprecipitation with an anti–Myc antibody as de-
scribed below. Various glutathione 
 
S
 
-transferase (GST)–fusion constructs
contained the following aa residues: GST–ponsin-2-F, 1–724 (the full
length); GST–ponsin-2-N, 1–400 (the NH
 
2
 
-terminal half); GST–ponsin-2-C,
401–724 (the COOH-terminal half); GST–ponsin-2-SH3(1
 
1
 
2), 460–631
(the first and second SH3 domains); GST–ponsin-2-SH3(2
 
1
 
3), 543–724
(the second and third SH3 domains); GST–ponsin-2-SH3(1), 460–558 (the
first SH3 domain); GST–ponsin-2-SH3(2), 543–631 (the second SH3
domain); GST–ponsin-2-SH3(3), 648–724 (the third SH3 domain); GST–
vinculin-P, 837–878 (the proline-rich region); and GST–vinculin-C-
 
D
 
P,
879–1066 (the COOH-terminal region lacking the proline-rich region). Six
histidine residues (His6)–fusion constructs contained the following aa res-
idues: His6–l-afadin-C199, 1631–1829 (the COOH-terminal 199 aa region
including the third proline-rich region); His6–l-afadin-C132, 1698–1829
[the COOH-terminal 132 aa region lacking the aa residues (PPLP) of the
third proline-rich region]. A maltose-binding protein (MBP)–fusion con-
struct (MBP–vinculin-C) contained the COOH-terminal half of vinculin
(aa 534–1066). The GST-, His6-, and MBP-fused proteins were purified by
use of glutathione-Sepharose beads (Amersham-Pharmacia Biotechnol-
ogy), TALON metal affinity beads (Clontech), and amylose resin beads
(New England Biolabs Inc.), respectively.
 
Immunoprecipitation and Affinity Chromatography
 
Immunoprecipitation experiments from COS7 cells were done as follows:
the eukaryote expression constructs described above were transfected to
COS7 cells with the DEAE-dextran method in various combinations
(Hata and Südhof, 1995). A lysis buffer (20 mM Tris-HCl at pH 7.5, 150
mM NaCl, 1% Triton X-100, 1 mM EDTA, and 1 mM EGTA) containing
protease inhibitors (20 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml pepstatin A, and 1 mM
PMSF) was added to the transfected COS7 cells. The cell extract (1.2 mg
protein), obtained by centrifugation at 100,000 
 
g
 
 for 1 h, was incubated
with either an anti–Myc antibody (11.5 
 
m
 
g of protein; Takaishi et al., 1995)
or an anti–FLAG M2 antibody (13.5 
 
m
 
g of protein; Eastman Kodak Scien-
tific Imaging Systems) at 4
 
8
 
C for 3 h. 20 
 
m
 
l of protein G–Sepharose 4 Fast
Flow beads (Amersham-Pharmacia Biotechnology) were added to this
sample and incubation was performed at 4
 
8
 
C for 1 h. After the beads were
washed with the lysis buffer, the bound proteins were eluted by boiling the
beads in an SDS sample buffer for 10 min. The samples were then sub-
jected to SDS-PAGE, followed by protein staining with Coomassie bril-
liant blue or by Western blot analysis.
Affinity chromatography was done as follows: various GST-fused pro-
teins of ponsin-2 and GST alone (200 pmol each) were separately immobi-
lized on 10 
 
m
 
l of glutathione-Sepharose beads (Amersham-Pharmacia
Biotechnology). His6–l-Afadin-C-199 (the COOH-terminal 199 aa region
including the third proline-rich region), His6–l-afadin-C132 (the COOH-
terminal 132 aa region lacking the aa residues [PPLP] of the third proline-
rich region), MBP–vinculin-C (the COOH-terminal half), or MBP alone
(200 pmol each) was incubated at 4
 
8
 
C overnight with the glutathione-
Sepharose beads in 100 
 
m
 
l of PBS containing 0.1% Triton X-100. For com-
petition experiments, His6–l-afadin-C199 (200 pmol or 2 nmol) and MBP-
vinculin-C (200 pmol or 2 nmol) were mixed and incubated with 10 
 
m
 
l of
the GST–ponsin-2-C (the COOH-terminal half)–immobilized beads in
400 
 
m
 
l of PBS containing 0.1% Triton X-100. The beads were extensively
washed with the same buffer. Elution was performed with PBS containing
20 mM glutathione.
 
Antibodies
 
A rabbit antiserum against ponsin was raised against GST–ponsin-2-SH3
(1) (the first SH3 domain). This antiserum was affinity-purified with GST–
ponsin-2-SH3(1) covalently coupled to NHS-activated Sepharose beads
(Amersham-Pharmacia Biotechnology) and used as a polyclonal anti-
ponsin antibody. A mouse monoclonal anti–l-afadin antibody was pre-
pared as described (Sakisaka et al., 1999). A rabbit polyclonal anti–l- and
s-afadin antibody, which recognized both l- and s-afadins, was prepared as
described (Mandai et al., 1997). A mouse monoclonal anti-vinculin anti-
body was purchased from Sigma Chemical Co. Rat monoclonal anti–
E-cadherin (ECCD2) and anti–P-cadherin (PCD1) antibodies were pur-
chased from TAKARA Shuzo, Inc. (Shiga).
 
Immunofluorescence and Immunoelectron Microscopy
 
Immunofluorescence microscopy of cultured cells and frozen sections of
various rat tissues was done as described (Itoh et al., 1991; Mandai et al.,
1997). Immunoelectron microscopy using the silver-enhancement tech-
nique was done as described (Mizoguchi et al., 1994; Mandai et al. 1997). 
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Other Procedures
 
125
 
I-Labeled F-actin blot overlay and F-actin cosedimentation were done
as described (Mandai et al., 1997; Satoh et al., 1998). Native vinculin was
purified from chicken gizzard as described (O’Halloran et al., 1986).
COS7, mouse mammary tumor MTD-1A, and rat 3Y1 cells were main-
tained in DME containing 10% FCS. Protein concentrations were deter-
mined with BSA as a reference protein (Bradford, 1976). SDS-PAGE was
done as described (Laemmli, 1970). Fluorescence in situ hybridization
(FISH) analysis was performed as described (Matsuda et al., 1992; Mat-
suda and Chapman, 1995).
 
Results
 
Purification of Ponsin and Molecular Cloning
of its cDNA
 
To identify an l-afadin–binding protein(s), we used a blot
overlay method with 
 
35
 
S-labeled l-afadin. When each sub-
cellular fraction of rat liver was subjected to SDS-PAGE,
followed by the blot overlay, a radioactive band of 
 
z
 
93 kD
(p93) was detected and enriched in the AJ-enriched frac-
tion (Fig. 1 A). p93 was a major binding partner for l-afa-
din in the AJ-enriched fraction. p93 was solubilized from
this fraction with a combination of urea and Triton X-100,
and highly purified by successive chromatographies of
Mono Q, hydroxyapatite, and Mono S columns. On the fi-
nal Mono S column chromatography, the radioactive band
with l-afadin–binding activity well coincided with a protein
of 
 
z
 
93 kD (Fig. 1 B). p93 was purified with two other ra-
dioactive bands of 
 
z
 
95 (p95) and 70 (p70) kD. They also
coincided with proteins of 
 
z
 
95 and 70 kD that were identi-
fied by protein staining with Coomassie brilliant blue. In
addition to these proteins, a radioactive band of 
 
z
 
55 kD
(p55) was detected, but this band remained to be charac-
terized.
These protein bands were separately cut out from the
gel and digested with a lysyl endopeptidase. The digested
peptides were separated by HPLC, and peptide maps of
these proteins were obtained. Their maps were similar to
each other, but the maps of p95 and p93 had additional
peptide peaks when compared with that of p70 (data not
shown). When two peptide peaks of each of p95, p93, and
p70, both of which were common among these proteins,
were separately sequenced, each of the three proteins
included the following peptide sequences: peptide-1,
LNRDDDSDLHSPRYSFSEDTK; peptide-2, CDDGW-
FVGTSRRTK. BLAST search of the GenBank database
indicated that these sequences were almost identical to
that of the mouse 
 
SH3P12
 
 gene product (U58883; Gen-
Bank/EMBL/DDBJ), which had originally been identified
as an SH3-containing protein (Sparks et al., 1996). These
results suggest that p95, p93, and p70 are related to
SH3P12.
We performed PCR to amplify the cDNA of SH3P12
using a mouse brain cDNA as a template, and isolated at
least 12 clones whose restriction maps were similar to but
 
Figure 1.
 
35
 
S-Labeled l-afadin–binding proteins. (A) Subcellular
distribution of 
 
35
 
S-labeled l-afadin–binding proteins in rat liver.
An aliquot (30 
 
m
 
g protein) of each subcellular fraction was sub-
jected to SDS-PAGE (8% polyacrylamide gel), followed by 
 
35
 
S-
 
labeled l-afadin blot overlay. (Arrow) p93, (Ho) homogenate,
(S1) soluble fraction, (P1) pellet fraction, (BC) fraction rich in
bile canaliculi, and (AJ) fraction rich in AJ. (B) 
 
35
 
S-Labeled
l-afadin–binding proteins in Mono S column chromatography.
(B1) Absorbance at 280 nm (A
 
280
 
). (B2) 
 
35
 
S-Labeled l-afadin blot
overlay. An aliquot (0.75 
 
m
 
l) of each fraction was subjected to
SDS-PAGE (8% polyacrylamide gel), followed by 
 
35
 
S-labeled
l-afadin blot overlay. (B3) Protein staining with Coomassie bril-
liant blue. An aliquot (2 
 
m
 
l) of each fraction was subjected to
SDS-PAGE (8% polyacrylamide gel), followed by protein stain-
ing with Coomassie brilliant blue. (Open arrowhead) p95, (closed
arrowhead) p93, (arrow) p70, and (double arrowhead) p55. The
results are representative of three independent experiments. 
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slightly different from each other (data not shown). We
determined the nucleotide sequences of two of them,
clones 2 and 17. Each clone contained an in-frame stop
codon upstream of the predicted initiation codon. The
protein encoded by clone 2 had 724 aa with a calculated
molecular weight of 81,217 (AF078666; GenBank/EMBL/
DDBJ) and the protein encoded by clone 17 had 714 aa
with a calculated molecular weight of 79,492 (AF078667;
GenBank/EMBL/DDBJ) (Fig. 2 A). Both the proteins in-
cluded the aa sequences identical to peptide-1 and -2, ex-
cept that L (at the 9th aa residue) and E (at the 18th aa
residue) of peptide-1 were replaced with V and D, respec-
tively, and K (at the 14th aa residue) of peptide-2 was re-
placed with R. This difference in the aa residues is likely to
be due to the species difference between mouse and rat.
When the aa sequences of clones 2, 17, and SH3P12 were
aligned, they were highly homologous (92% aa identity
between clone 2 and SH3P12 and 96% aa identity between
Figure 2. Molecular charac-
terization of ponsin-1 and -2.
(A) Deduced amino acid se-
quences of ponsin-1, -2, and
SH3P12. Identity is high-
lighted. Signaling domain or-
ganization was determined
with the Web-based tool,
SMART (simple modular ar-
chitecture research tool) pro-
gram (Schultz et al., 1998).
(B) l-Afadin–binding activ-
ity of ponsin-1 and -2. Myc–
ponsin-1 (the full length) or
-2 (the full length) was ex-
pressed in COS7 cells by
transfection with pCMV-Myc–
ponsin-1 or -2, respectively.
The Myc-tagged protein was
immunoprecipitated with the
anti–Myc antibody, and then
subjected to SDS-PAGE (8%
polyacrylamide gel), followed
by  35S-labeled l-afadin blot
overlay or protein staining
with Coomassie brilliant
blue. An aliquot (2 ml) of
fraction 10 in the Mono S
column chromatography was
also subjected to SDS-
PAGE, followed by 35S-
labeled l-afadin blot overlay
or by protein staining. (B1)
35S-Labeled l-afadin blot
overlay, and (B2) protein
staining. The results are rep-
resentative of three indepen-
dent experiments. 
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clone 17 and SH3P12) but their differences were clustered
and not distributed throughout the sequences (Fig. 2 A).
To examine whether clones 2 and 17 were derived from
the same locus, we made the chromosomal assignment by
the FISH analysis using the cDNAs as probes. Clones 2
and 17 were located at the same locus (data not shown).
These results suggest that clones 2, 17, and SH3P12 were
splicing variants derived from the same gene.
To examine whether the protein encoded by clone 2 or
17 was the mouse counterpart of p95, p93, or p70, we con-
structed a Myc-tagged mammalian expression vector with
each DNA, and expressed the protein in COS7 cells. The
Myc-tagged recombinant protein was immunoprecipitated
with the anti–Myc antibody and subjected to SDS-PAGE,
followed by 
 
35
 
S-labeled l-afadin blot overlay. The protein
encoded by clone 17 showed a mobility similar to that of
native p93 on SDS-PAGE and the 
 
35
 
S-labeled l-afadin–
binding activity (Fig. 2 B). On the basis of these observa-
tions, we concluded that clone 17 encoded the full-length
cDNA of the mouse counterpart of p93 and named it pon-
sin-1, although we did not know the reason for the differ-
ence between the molecular mass value calculated from
the predicted aa sequence and that estimated by SDS-
PAGE. On the other hand, the protein encoded by clone 2
had the 
 
35
 
S-labeled l-afadin–binding activity, but showed a
mobility between p93 and p95 on SDS-PAGE. Thus, we
could not conclude whether p95 was encoded by clone 2.
The protein encoded by clone 2 was named ponsin-2. Pon-
sin-2 appeared to bind 
 
35
 
S-labeled l-afadin more than pon-
sin-1 under the conditions used here. Hydrophilicity analy-
sis of ponsin-1 and -2 predicted that these proteins had no
transmembrane region (data not shown). Computer analy-
sis of domain organization indicated that ponsin-1 and -2
had three SH3 domains at their COOH-terminal regions
and two sorbin-like regions at their NH
 
2
 
-terminal regions,
but did not have other known signaling domains (Fig. 2 A).
 
Binding of l-Afadin to Ponsin
 
We confirmed the binding of l-afadin to ponsin by an im-
munoprecipitation method. Myc–l-afadin (the full length)
and FLAG–ponsin (the full length) were transiently co-
expressed in COS7 cells. When FLAG–ponsin-2 was im-
munoprecipitated with the anti–FLAG antibody, Myc–
l-afadin was coprecipitated (Fig. 3 A). Conversely, when
Myc–l-afadin was immunoprecipitated with the anti–Myc
antibody, FLAG–ponsin-2 was coprecipitated. Similarly,
FLAG–ponsin-2 and tag-free l-afadin (the full length) or
s-afadin (the full length) were transiently coexpressed in
COS7 cells. When FLAG–ponsin-2 was immunoprecipi-
tated with the anti–FLAG antibody, most of l-afadin was
coprecipitated, but s-afadin was coprecipitated to a small
extent and mostly recovered in the supernatant fraction
(Fig. 3 B). The essentially same results were obtained with
ponsin-1 (data not shown). These results indicate that pon-
sin binds mainly l-afadin and slightly s-afadin.
To examine the possibility that ponsin was an F-actin–
binding protein and bound l-afadin through F-actin, we
performed 
 
125
 
I-labeled F-actin blot overlay and F-actin
cosedimentation using the recombinant proteins as de-
scribed (Mandai et al., 1997; Satoh et al., 1998). GST–pon-
sin-2-F (the full length) did not bind to F-actin under the
Figure 3. Binding of l-afadin to ponsin in vivo. (A) Immunopre-
cipitation analysis of l-afadin and ponsin-2. FLAG–ponsin-2 (the
full length) and Myc–l-afadin (the full length) were coexpressed
in COS7 cells in various combinations by transfection with
pFLAG-CMV2–ponsin-2 and pCMV-Myc–l-afadin, respec-
tively. Each cell extract was subjected to immunoprecipitation
with the anti–FLAG or anti–Myc antibody. The precipitate was
then subjected to SDS-PAGE (8% polyacrylamide gel), followed
by Western blot analysis using the anti–FLAG or anti–Myc anti-
body, or by protein staining with Coomassie brilliant blue. (A1)
Western blot analysis, and (A2) protein staining. (IP) Immuno-
precipitation, and (CBB) staining with Coomassie brilliant blue.
(B) Immunoprecipitation analysis of s-afadin and ponsin-2. Both
FLAG–ponsin-2 and tag-free l-afadin (the full length) or both
FLAG–ponsin-2 and tag-free s-afadin (the full length) were coex-
pressed in COS7 cells by transfection with both pFLAG-CMV2–
ponsin-2 and pCMV5–l-afadin or both pFLAG-CMV2–ponsin-2
and pCMV5–s-afadin, respectively. Each cell extract was incu-
bated with the anti–FLAG antibody and protein G–Sepharose
beads, followed by centrifugation. The beads and the supernatant
were separately subjected to SDS-PAGE (8% polyacrylamide
gel), followed by Western blot analysis using the anti–l- and
s-afadin antibody. (Sup) supernatant. The results are representa-
tive of three independent experiments. 
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conditions where l-afadin bound to F-actin (data not
shown).
 
Binding Regions of l-Afadin and Ponsin
 
We first determined the ponsin-binding region of l-afadin.
 
35
 
S-labeled ponsin-2 blot overlay analysis revealed that
Myc–l-afadin (the full length), but not Myc–s-afadin
(the  full length) that lacked the third proline-rich region,
bound to ponsin-2 (Fig. 4 A1). His6–l-Afadin-C199 (the
COOH-terminal 199 aa region including the third proline-
rich region), but not His6–l-afadin-C132 (the COOH-ter-
minal 132 aa region lacking the aa residues [PPLP] of the
third proline-rich region), bound to ponsin-2. These re-
sults suggest that the third proline-rich region of l-afadin
binds to ponsin.
We next determined the l-afadin–binding region of pon-
sin. 
 
35
 
S-Labeled l-afadin blot overlay analysis revealed that
 
GST–ponsin-2-F (the full length) and GST–ponsin-2-C
(the COOH-terminal half) bound to l-afadin (Fig. 4 A2).
In contrast, GST–ponsin-2-N (the NH
 
2
 
-terminal half) did
not show this activity. In the COOH-terminal half of pon-
sin-2, GST–ponsin-2-SH3(2
 
1
 
3) (the second and third SH3
domains) showed this activity, but GST–ponsin-2-SH3
(1
 
1
 
2) (the first and second SH3 domains) did not. When
each of the three SH3 domains was used, neither GST–
ponsin-2-SH3(1) (the first SH3 domain), GST–ponsin-2-SH3
(2) (the second SH3 domain), nor GST–ponsin-2-SH3(3)
(the third SH3 domain) bound to l-afadin. These results
suggest that the region containing the second and third
SH3 domains binds to l-afadin.
We furthermore examined the binding regions of l-afa-
din and ponsin by an affinity chromatography method us-
ing the recombinant proteins. Consistent with the results
by the blot overlay method, His6–l-afadin-C199 bound to
GST–ponsin-2-C immobilized on glutathione-Sepharose
Figure 4. Binding regions of
l-afadin and ponsin. (A) Blot
overlay. (A1) 35S-Labeled pon-
sin-2 blot overlay. Myc–l-Afadin
(the full length), Myc–s-afadin
(the full length), His6–l-afa-
din-C199 (the COOH-terminal
199 aa region including the third
proline-rich region), and His6–
l-afadin-C132 (the COOH-termi-
nal 132 aa region lacking the aa
residues [PPLP] of the third pro-
line-rich domain) (5 pmol each)
were subjected to SDS-PAGE
(8 and 12% discontinuous poly-
acrylamide gel), followed by
35S-labeled ponsin-2 blot over-
lay. (A2) 35S-Labeled l-afadin
blot overlay. Various GST-fused
proteins of ponsin-2 (5 pmol
each) were subjected to SDS-
PAGE (8% polyacrylamide
gel), followed by 35S-labeled
l-afadin blot overlay. (B) Affin-
ity chromatography. (B1) Bind-
ing region of l-afadin. His6–l-Afa-
din-C199 or His6–l-afadin-C132
was incubated with GST–pon-
sin-2-C (the COOH-terminal
half) or GST alone immobilized
on glutathione-Sepharose beads.
Each original sample and eluate
were subjected to SDS-PAGE
(15% polyacrylamide gel), fol-
lowed by protein staining with
Coomassie brilliant blue. (B2)
Binding region of ponsin. His6–
l-afadin-C199 was incubated
with various GST-fused proteins
of ponsin-2 immobilized on glutathione-Sepharose beads. Each eluate was subjected to SDS-PAGE (12% polyacrylamide gel), fol-
lowed by Western blot analysis using the anti–l-afadin antibody. [PR(1)] the first proline-rich region (aa 1219–1229), [PR(2)] the second
proline-rich region (aa 1372–1399), [PR(3)] the third proline-rich region (aa 1691–1713), (C199) His6–l-afadin-C199, (C132) His6–l-afa-
din-C132, (F) GST–ponsin-2-F (the full length), (N) GST–ponsin-2-N (the NH2-terminal half), (C) GST–ponsin-2-C, [SH3(112)] GST–
ponsin-2-SH3(112) (the first and second SH3 domains), [SH3(213)] GST–ponsin-2-SH3(213) (the second and third SH3 domains),
[SH3(1)] GST–ponsin-2-SH3(1) (the first SH3 domain), [SH3(2)] GST–ponsin-2-SH3(2) (the second SH3 domain), and [SH3(3)] GST–
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beads, whereas His6–l-afadin-C132 did not (Fig. 4 B1).
His6–l-afadin-C199 bound to GST–ponsin-2-F, GST–pon-
sin-2-C, and GST–ponsin-2-SH3(213), but not to GST–
ponsin-2-N, GST–ponsin-2-SH3(112), GST–ponsin-2-SH3
(1), or GST–ponsin-2-SH3(2) (Fig. 4 B2). In contrast,
His6–l-afadin-C199 slightly bound to GST–ponsin-2-SH3
(3). This inconsistency may be due to the sensitivity differ-
ence between the two methods.
Binding of Ponsin to Vinculin
Because ponsin-1 and -2 were predicted not to be integral
membrane proteins as described above, these proteins by
themselves would not determine the specific localiza-
tion of l-afadin at ZA in epithelial cells and at cell–cell
AJ in nonepithelial cells. To explore another molecule(s)
through which l-afadin was localized there, we further-
more attempted to identify a ponsin-binding protein(s).
To identify the protein(s), we performed a blot overlay
method with 35S-labeled ponsin-2. When each subcellular
fraction of rat liver was subjected to SDS-PAGE, followed
by the blot overlay, a radioactive band of z120 kD was de-
tected and relatively enriched in the AJ-enriched fraction
(Fig. 5 A). Each fraction from the Mono Q column chro-
matography, which was used for the purification of ponsin,
was subjected to 35S-labeled ponsin-2 blot overlay. The ra-
dioactive band of z120 kD was detected in fractions 19–29
(Fig. 5 B1). The radioactive band well coincided with a
protein band of z120 kD that was identified by protein
staining with Coomassie brilliant blue (data not shown).
This protein was recognized by the anti-vinculin antibody,
suggesting that ponsin directly binds vinculin (Fig. 5 B2).
We confirmed the binding of ponsin to vinculin by an
immunoprecipitation method. Because vinculin shows the
intramolecular association of its NH2- and COOH-termi-
nal halves (Johnson and Craig, 1995), we used the COOH-
and NH2-terminal halves of vinculin. FLAG–ponsin-2
(the full length) and Myc–vinculin-C (the COOH-terminal
half) were transiently coexpressed in COS7 cells. When
FLAG–ponsin-2 was immunoprecipitated with the anti–
FLAG antibody, Myc–vinculin-C was coprecipitated (Fig.
6). Conversely, when Myc–vinculin-C was immunoprecipi-
tated with the anti–Myc antibody, FLAG–ponsin-2 was
coprecipitated. When Myc–vinculin-N (the NH2-terminal
half) was used instead of Myc–vinculin-C, FLAG–ponsin-2
or Myc–vinculin-N was not coimmunoprecipitated. The
Figure 5. Binding of ponsin to vinculin in vitro. (A) Subcellular
distribution of 35S-labeled ponsin-2–binding proteins in rat liver.
An aliquot (60 mg protein) of each subcellular fraction was sub-
jected to SDS-PAGE (8% polyacrylamide gel), followed by 35S-
labeled ponsin-2 blot overlay. (Ho) homogenate, (S1) soluble
fraction, (P1) pellet fraction, (BC) fraction rich in bile canaliculi,
and (AJ) fraction rich in AJ. (B) Mono Q column chromatogra-
phy of 35S-labeled ponsin-2–binding proteins. (B1)  35S-labeled
ponsin-2 blot overlay. An aliquot (10 ml) of each fraction was
subjected to SDS-PAGE (8% polyacrylamide gel), followed by
35S-labeled ponsin-2 blot overlay. (B2) Western blot analysis. An
aliquot (4 ml) of each fraction was subjected to SDS-PAGE (8%
polyacrylamide gel), followed by Western blot analysis using the
anti-vinculin antibody. The results are representative of three in-
dependent experiments.
Figure 6. Immunoprecipitation analysis of ponsin-2 and vinculin.
FLAG–ponsin-2 (the full length), Myc–vinculin-N (the NH2-ter-
minal half), and Myc–vinculin-C (the COOH-terminal half) were
expressed in COS7 cells in various combinations by transfection
with pFLAG-CMV2–ponsin-2, pCMV-Myc–vinculin-N, and
pCMV-Myc–vinculin-C, respectively. Each cell extract was sub-
jected to immunoprecipitation with the anti–FLAG or anti–Myc
antibody. The precipitate was then subjected to SDS-PAGE (8%
polyacrylamide gel), followed by Western blot analysis using the
anti–FLAG or anti–Myc antibody. (IP) Immunoprecipitation.
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essentially same results were obtained with ponsin-1 (data
not shown). These results indicate that ponsin binds not
only l-afadin but also vinculin both in cell-free and intact
cell systems.
Binding Regions of Ponsin and Vinculin
We first examined the vinculin-binding region of ponsin.
35S-labeled vinculin blot overlay analysis revealed that
GST–ponsin-2-F (the full length) and GST–ponsin-2-C
(the COOH-terminal half) bound to vinculin (Fig. 7 A1).
In contrast, GST–ponsin-2-N (the NH2-terminal half) did
not show this activity. In the COOH-terminal half of pon-
sin, GST–ponsin-2-SH3(112) (the first and second SH3
domains) bound to vinculin, whereas neither GST–ponsin-
2-SH3(1) (the first SH3 domain) nor GST–ponsin-2-SH3
(3) (the third SH3 domain) bound. GST–ponsin-2-SH3
(213) (the second and third SH3 domains) and GST–pon-
sin-2-SH3(2) (the second SH3 domain) slightly bound to
vinculin. These results suggest that the region containing
the first and second SH3 domains binds to vinculin.
We next examined the ponsin-binding region of vincu-
lin. Consistent with the results by the immunoprecipitation
method, 35S-labeled ponsin-2 blot overlay analysis revealed
that native vinculin and Myc–vinculin-2 (the COOH-ter-
minal region, aa 801–1066), but not Myc–vinculin-1 (the
NH2-terminal region, aa 1–800), bound to ponsin-2 (Fig. 7
A2). GST–vinculin-P (the proline-rich region), but not
Figure 7. Binding regions of
ponsin and vinculin. (A) Blot
overlay. (A1) 35S-Labeled vincu-
lin blot overlay. Various GST-
fused proteins of ponsin-2 (5
pmol each) were subjected to
SDS-PAGE (8% polyacrylamide
gel), followed by 35S-labeled vin-
culin blot overlay. (A2) 35S-
Labeled ponsin-2 blot overlay.
Full-length native vinculin and
various recombinant proteins of
vinculin (5 pmol each) were sub-
jected to SDS-PAGE (8 and
12% discontinuous polyacryl-
amide gel), followed by 35S-
labeled ponsin blot overlay. (B)
Affinity chromatography. (B1)
Binding region of ponsin. MBP–
vinculin-C (the COOH-ter-
minal half) was incubated with
various GST-fused proteins of
ponsin-2 immobilized on glu-
tathione-Sepharose beads. Each
eluate was subjected to SDS-
PAGE (10% polyacrylamide
gel), followed by Western blot
analysis using the anti-vinculin
antibody. (B2) Binding region
of vinculin. MBP–vinculin-C or
MBP alone was incubated with
GST–ponsin-2-C (the COOH-
terminal half) or GST alone im-
mobilized on glutathione-Seph-
arose beads. Each original
sample and eluate were sub-
jected to SDS-PAGE (12%
polyacrylamide gel), followed
by protein staining with Coo-
massie brilliant blue. (F) GST–
ponsin-2-F (the full length), (N)
GST–ponsin-2-N (the NH2-ter-
minal half), (C) GST–ponsin-
2-C, [SH3(112)] GST–ponsin-2-SH3(112) (the first and second SH3 domains), [SH3(213)] GST–ponsin-2-SH3(213) (the second and
third SH3 domains), [SH3(1)] GST–ponsin-2-SH3(1) (the first SH3 domain), [SH3(2)] GST–ponsin-2-SH3(2) (the second SH3
domain), [SH3(3)] GST–ponsin-2-SH3(3) (the third SH3 domain), [PR] the proline-rich region of vinculin (aa 837–878), (1) Myc–vincu-
lin-1 (the NH2-terminal region, aa 1–800), (2) Myc–vinculin-2 (the COOH-terminal region, aa 801–1066); (P) GST–vinculin-P (the pro-
line-rich region), and (C-DP) GST–vinculin-C-DP (the COOH-terminal region lacking the proline-rich region). The results are repre-
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GST–vinculin-C-DP (the COOH-terminal region lacking
the proline-rich region), bound to ponsin-2. These results
suggest that the proline-rich region of vinculin binds to
ponsin. The proline-rich region has two proline-rich se-
quences, one of which binds to the cytoskeletal protein,
vasodilator-stimulated phosphoprotein (VASP; Brindle et
al., 1996; Niebuhr et al., 1997). It remains to be clarified
which proline-rich sequence of vinculin is responsible for
the binding to ponsin.
We furthermore examined the binding regions of ponsin
and vinculin by an affinity chromatography method using
the recombinant proteins. Consistent with the results by
the immunoprecipitation and blot overlay methods, MBP–
vinculin-C (the COOH-terminal half) bound to GST–pon-
sin-2-F, GST–ponsin-2-C, and GST–ponsin-2-SH3(112),
but not to GST–ponsin-2-SH3(1) or GST–ponsin-2-SH3
(3) (Fig. 7 B1). MBP–vinculin-C slightly bound to GST–
ponsin-2-SH3(213) and GST–ponsin-2-SH3(2). When MBP
alone was used instead of MBP–vinculin-C, MBP alone did
not bind to GST–ponsin-2-C (Fig. 7 B2).
Inability of Ponsin to Form a Ternary Complex with
l-Afadin and Vinculin
The above result that the l-afadin– and vinculin-binding
regions of ponsin are partly overlapped suggests that l-afa-
din and vinculin bind to ponsin in a competitive manner
and that these three proteins do not form a ternary com-
plex. We examined this possibility by two different meth-
ods, immunoprecipitation and affinity chromatography.
When FLAG–ponsin-2 (the full length) alone was tran-
siently expressed in COS7 cells and immunoprecipitated
with the anti–FLAG antibody, both endogenous l-afadin
and vinculin were coprecipitated (Fig. 8 A1). However, it
was not clear from this result whether a ternary complex
of ponsin, l-afadin, and vinculin, or a mixture of binary
complexes of ponsin and l-afadin and of ponsin and vincu-
lin was coprecipitated. To address this issue, we examined
whether ponsin and l-afadin or ponsin and vinculin were
coprecipitated when vinculin or l-afadin was immunopre-
cipitated, respectively. Both FLAG–ponsin-2 and Myc–
vinculin-C (the COOH-terminal half) were transiently
coexpressed in COS7 cells. When Myc–vinculin-C was im-
munoprecipitated with the anti–Myc antibody, FLAG–
ponsin-2, but not endogenous l-afadin, was coprecipitated
(Fig. 8 A2). When FLAG–ponsin-2 was immunoprecipi-
tated with the anti–FLAG antibody, both Myc–vinculin-C
and endogenous l-afadin were coprecipitated, but the
amount of the precipitated l-afadin was reduced, com-
pared with that from COS7 cells expressing FLAG–pon-
sin-2 alone. Next, both FLAG–ponsin-2 and Myc–l-afadin
(the full length) were transiently coexpressed in COS7
Figure 8. Inability of ponsin to form a ternary complex with l-afadin and vinculin. (A) Immunoprecipitation from COS7 cells. Myc–
l-afadin (the full length), FLAG–ponsin-2 (full length), and Myc–vinculin-C (the COOH-terminal half) were expressed in COS7 cells in
various combinations by transfection with pCMV-Myc–l-afadin, pFLAG-CMV2–ponsin-2, and pCMV-Myc–vinculin-C, respectively.
Each cell extract was subjected to immunoprecipitation with the anti–Myc or anti–FLAG antibody. The precipitate was then subjected
to SDS-PAGE (8% polyacrylamide gel), followed by Western blot analysis using the anti–Myc, anti–FLAG, anti–l-afadin, or anti-vin-
culin antibody. (A1) COS7 cells expressing FLAG–ponsin-2 alone, (A2) COS7 cells expressing both FLAG–ponsin-2 and Myc–vincu-
lin-C, (A3) COS7 cells expressing both Myc–l-afadin and FLAG–ponsin-2. (IP) Immunoprecipitation. (B) Affinity chromatography us-
ing ponsin-immobilized beads. Various doses of His6–l-afadin-C199 (the COOH-terminal 199 aa region including the third proline-rich
region) and MBP–vinculin-C (the COOH-terminal half) were mixed and incubated with GST–ponsin-2-C (the COOH-terminal half)
immobilized on glutathione-Sepharose beads. Each eluate was subjected to SDS-PAGE (15% polyacrylamide gel), followed by protein
staining with Coomassie brilliant blue. The results are representative of three independent experiments.Mandai et al. Ponsin: An l-AfadinÐ and Vinculin-binding Protein 1011
cells. When Myc–l-afadin was immunoprecipitated with
the anti–Myc antibody, FLAG–ponsin-2, but not endoge-
nous vinculin, was coprecipitated (Fig. 8 A3). When
FLAG–ponsin-2 was immunoprecipitated with the anti–
FLAG antibody, both Myc–l-afadin and endogenous vin-
culin were coprecipitated, but the amount of the precipi-
tated vinculin was reduced compared with that from COS7
cells expressing FLAG–ponsin-2 alone. These results sug-
gest that l-afadin and vinculin bind to ponsin in a competi-
tive manner, and that l-afadin, ponsin, and vinculin hardly
form a ternary complex.
We confirmed this conclusion by an affinity chromatog-
raphy method using the recombinant proteins. His6–l-Afa-
din-C199 (the COOH-terminal 199 aa region including the
third proline-rich region) was mixed with MBP–vinculin-C
(the COOH-terminal half) and incubated with GST–pon-
sin-2-C (the COOH-terminal half) immobilized on glu-
tathione-Sepharose beads. When the concentration of
His6–l-afadin-C199 was fixed and the concentration of
MBP–vinculin-C was increased, the amount of the bound
His6–l-afadin-C199 was decreased, whereas the amount of
the bound MBP–vinculin-C was increased (Fig. 8 B). Con-
versely, when the concentration of His6–l-afadin-C199 was
increased and the concentration of MBP–vinculin-C was
fixed, the amount of the bound His6–l-afadin-C199 was in-
creased, whereas the amount of the bound MBP–vincu-
lin-C was decreased. The exact affinities of l-afadin and
vinculin to ponsin were not examined, but their affinities
were apparently similar.
We confirmed that l-afadin and vinculin did not bind to
each other. Myc–l-afadin or Myc–vinculin-C alone was
transiently expressed in COS7 cells. When Myc–l-afadin
was immunoprecipitated with the anti–Myc antibody, en-
dogenous vinculin was not precipitated (Fig. 8 A3). Simi-
larly, when Myc–vinculin-C was immunoprecipitated with
the anti–Myc antibody, endogenous l-afadin was not pre-
cipitated (Fig. 8 A2).
Tissue Distribution and Intracellular Localization
of Ponsin
In the next series of experiments, we analyzed the tissue
distribution and intracellular localization of ponsin. North-
ern blot analysis using ponsin-2 as a probe showed that
ponsin was ubiquitously expressed in all the mouse tissues
examined, including heart, brain, spleen, lung, liver, skele-
tal muscle, kidney, and testis (Fig. 9 A). In heart, brain,
liver, and skeletal muscle, several bands were detected,
consistent with the above result that ponsin had several
splicing variants. Western blot analysis using the anti-pon-
sin antibody showed that ponsin as well as l-afadin was
concentrated in the AJ-enriched fraction of liver (Fig. 9
B). This antibody specifically recognized p93 (ponsin-1),
p95, and p70. Vinculin was detected in all the fractions and
relatively concentrated in the AJ-enriched fraction (Fig. 9 B).
To determine the intracellular localization of ponsin, we
performed immunofluorescence microscopy of cultured
cells and various rat tissues. At the junctional level of
mouse mammary tumor MTD-1A cells, ponsin was colo-
calized with l-afadin and vinculin at cell–cell AJ (Fig. 10).
At the basal level, ponsin was colocalized with vinculin at
cell–matrix AJ where l-afadin was not localized. In rat 3Y1
Figure 9. Tissue and subcellular distribution of ponsin. (A)
Northern blot analysis. A mouse RNA blot membrane (Clon-
tech) was hybridized with the 32P-labeled full-length cDNA of
ponsin-2, followed by autoradiography with 48- or 8-h exposure.
(A1) 48-h exposure, and (A2) 8-h exposure. (B) Subcellular dis-
tribution in rat liver. An aliquot (15 mg protein) of each subcellu-
lar fraction was subjected to SDS-PAGE (8% polyacrylamide
gel), followed by Western blot analysis using the anti-ponsin,
anti–l-afadin, or anti-vinculin antibody. (Ho) homogenate, (S1)
soluble fraction, (P1) pellet fraction, (BC) fraction rich in bile
canaliculi, and (AJ) fraction rich in AJ.The Journal of Cell Biology, Volume 144, 1999 1012
To examine the precise localization of ponsin in the
junctional complex region, we performed immunoelectron
microscopy of rat small intestine absorptive epithelial cells
using the silver enhancement technique. Ponsin was asso-
ciated with the undercoat of ZA where l-afadin is localized
(Mandai et al., 1997) (Fig. 12 D).
Discussion
In this study, we isolated an l-afadin– and vinculin-binding
protein, named ponsin, which was ubiquitously expressed
and colocalized with vinculin at ZA in epithelial cells, at
cell–cell AJ in nonepithelial cells, and at cell–matrix AJ
in both types of cells (Fig. 13). We first purified three 35S-
l-afadin–binding proteins, p95, p93, and p70, from the AJ-
enriched fraction of rat liver. We then analyzed the pep-
tide maps and sequences of these proteins and found that
they were related to each other. Based on their peptide se-
quences, we obtained the mouse cDNAs of ponsin-1 and
-2. Ponsin-1 was likely a mouse counterpart of rat p93.
fibroblasts, ponsin was colocalized with l-afadin, vinculin,
and P-cadherin at cell–cell AJ and with vinculin at cell–
matrix AJ (Fig. 11). When the frozen sections of rat small
intestine were doubly stained with the monoclonal anti–
E-cadherin antibody, ponsin was concentrated with E-cad-
herin at the junctional complex region of absorptive epi-
thelial cells, but ponsin was more highly concentrated at
the junctional complex region than E-cadherin was (Fig.
12 A). When the frozen sections of rat heart were doubly
stained with the monoclonal anti-vinculin antibody, ponsin
was colocalized with vinculin at the intercalated disc. They
were also periodically located along the lateral borders of
cardiac muscle cells (costamere) (Fig. 12 B). In liver, pon-
sin showed the beltlike localization along the bile canali-
culi (Fig. 12 C). This localization was consistent with its
subcellular distribution in liver (see Fig. 9 B). These re-
sults indicate that ponsin is localized at both cell–cell
and cell–matrix AJs, although l-afadin is localized only at
cell–cell AJ, and that ponsin is colocalized with l-afadin at
cell–cell AJ. 
Figure 10. Localization of l-afadin, ponsin, and vinculin in cultured mouse mammary tumor MTD-1A cells. The cells were doubly
stained with the rabbit anti-ponsin and mouse anti–l-afadin antibodies, or with the rabbit anti-ponsin and mouse anti-vinculin antibod-
ies. There were nuclear stainings with this anti-ponsin antibody, but its significance was not clear. (A) The double staining with the anti-
ponsin and anti–l-afadin antibodies. (A1 and A3) Ponsin, (A2 and A4) l-afadin, (A1 and A2) junctional level, and (A3 and A4) basal
level. (B) The double staining with the anti-ponsin and anti-vinculin antibodies. (B1, B3, and B5) Ponsin, (B2, B4, and B6) vinculin, (B1
and B2) junctional level, (B3 and B4) middle level, and (B5 and B6) basal level. Bars: (A) 25 mm and (B) 50 mm. The results are repre-
sentative of three independent experiments.Mandai et al. Ponsin: An l-AfadinÐ and Vinculin-binding Protein 1013
However, ponsin-2 did not show the same mobility to that
of p95 or p70 on SDS-PAGE. During the molecular clon-
ing of ponsin, we obtained at least 12 independent clones,
all of which had the similar restriction maps. Northern blot
analysis indicated that ponsin had several mRNA bands in
heart, brain, liver, and skeletal muscle. When the aa se-
quences of ponsin-1 and -2 were aligned together with that
of SH3P12, they were highly homologous but their differ-
ences were clustered and not distributed throughout the
sequences. Moreover, the FISH analysis indicated that
ponsin-1 and -2 were located at the same locus (data not
shown). We have determined neither the genetic locus of
SH3P12 nor the clones other than ponsin-1 and -2, but
ponsin/SH3P12 had many splicing variants, and all of these
variants might be derived from the same gene. The exact
relationship of the 35S-l-afadin–binding proteins (p95 and
p70) and ponsin-1 and -2 has not been clarified here, but
there are two possibilities: (a) p95 and p70 are splicing
variants of ponsin other than ponsin-1 and -2, and (b) they
are posttranslationally modified forms of ponsin-1 or -2,
such as the phosphorylated or proteolytic form. The physi-
ological significance of the presence of many splicing vari-
ants of ponsin is unknown at present.
We presented the evidence that l-afadin bound to pon-
sin by four different methods: (a) blot overlay, (b) affinity
chromatography, (c) immunoprecipitation, and (d) im-
munofluorescence and immunoelectron microscopy. Blot
overlay analysis indicated that ponsin-2 appeared to bind
l-afadin more than ponsin-1, but their exact binding affini-
ties remain to be clarified. We moreover showed that the
binding regions of l-afadin and ponsin were the third pro-
line-rich region and the region containing the second and
third SH3 domains, respectively, consistent with the ear-
lier observation that proline-rich sequences interact with
either profilin or SH3 domains (Tanaka and Shibata, 1985;
Yu et al., 1994). Affinity chromatography analysis on each
SH3 domain indicated that the third SH3 domain bound to
l-afadin, whereas neither the first nor second SH3 domain
bound, suggesting that the third SH3 domain is the mini-
mal l-afadin–binding region. However, the l-afadin–bind-
ing activity of the third SH3 domain alone was less than
that of the region containing the second and third SH3 do-
mains. It remains to be clarified why the l-afadin–binding
activity of ponsin is reduced when the second and third
SH3 domains are separated from each other, but the
highly ordered structure of the region containing the sec-
ond and third SH3 domains may be necessary for the more
efficient binding of ponsin to l-afadin. In contrast to l-afa-
din, s-afadin, which has the first and second proline-rich
regions but lacks the third proline-rich region, hardly
bound to ponsin. Neurabin-II, which also has three pro-
line-rich regions (Satoh et al., 1998), did not bind to ponsin
either (data not shown). These results suggest that the
SH3 domains of ponsin recognize a specific proline-rich
region.
Computer analysis indicated that ponsin-1 and -2 had
three SH3 domains and two sorbin-like regions, but no
transmembrane region or other known signaling domains.
However, ponsin was localized at ZA in epithelial cells, at
cell–cell AJ in nonepithelial cells, and at cell–matrix AJ in
both types of cells (Fig. 13). These results suggest that
there is another protein that determines the specific local-
ization of l-afadin at these specific sites of cells. Along this
line, we found here that ponsin-1 and -2 bound vinculin,
which interacts with a-catenin at cell–cell AJ (Watabe-
Uchida et al., 1998; Weiss et al., 1998) and with talin at
cell–matrix AJ (Burridge and Mangeat, 1984). a-Catenin
interacts with cadherin through b-catenin (Aberle et al.,
1994), whereas talin directly interacts with integrin (Hor-
witz et al., 1986). We presented here the evidence that
ponsin directly bound vinculin by four different methods:
(a) blot overlay, (b) affinity chromatography, (c) immu-
noprecipitation, and (d) immunofluorescence and immu-
noelectron microscopy. Moreover, we showed that the
binding regions of ponsin and vinculin were the region
containing the first and second SH3 domains and the pro-
line-rich region, respectively. The proline-rich region of
vinculin is divided into at least two proline-rich sequences,
the first of which binds to vasodilator-stimulated phos-
Figure 11. Localization of l-afadin, ponsin, vinculin, and P-cad-
herin in cultured rat 3Y1 fibroblasts. (A) The double staining
with the anti-ponsin and anti–l-afadin antibodies. (A1) Ponsin
and (A2) l-afadin. (B) The double staining with the anti-ponsin
and anti-vinculin antibodies. (B1) Ponsin and (B2) vinculin. (C)
The double staining with the anti-ponsin and anti–P-cadherin an-
tibodies. (C1) Ponsin and (C2) P-cadherin. (Arrows) Cell–cell
AJ. Bars: 25 mm. The results are representative of three indepen-
dent experiments.The Journal of Cell Biology, Volume 144, 1999 1014
phoprotein (VASP) (Brindle et al., 1996; Niebuhr et al., 1997).
We have not determined which proline-rich sequence is
responsible for the binding to ponsin. Blot overlay and af-
finity chromatography analyses on each SH3 domain indi-
cated that the second SH3 domain bound to vinculin,
whereas neither the first nor third SH3 domain bound,
suggesting that the second SH3 domain is the minimal vin-
culin-binding region. However, the vinculin-binding activi-
ties of the second SH3 domain alone and the region con-
taining the second and third SH3 domains were less than
that of the region containing the first and second SH3 do-
mains. It remains to be clarified why the vinculin-binding
activity of ponsin is reduced when the first and second
SH3 domains are separated from each other. The highly
ordered structure of the region containing the first and
second SH3 domains may be necessary for the more effi-
cient binding of ponsin to vinculin.
The result (the l-afadin– and vinculin-binding regions of
ponsin were partly overlapped) suggested that l-afadin
and vinculin bind to ponsin in a competitive manner and
that these three proteins do not form a ternary complex.
Consistently, we found that l-afadin and vinculin bound to
ponsin in a competitive manner and that the affinities of
l-afadin and vinculin to ponsin were apparently similar.
We found here by immunoprecipitation and affinity chro-
matography analyses that ponsin formed a binary complex
with either l-afadin or vinculin, but hardly formed a ter-
nary complex with l-afadin and vinculin. This result sug-
gests that ponsin does not serve as a direct linker between
l-afadin and vinculin. The physiological significance of the
result that ponsin forms a binary complex with either l-afa-
din or vinculin at the same time but not a ternary complex
with the two F-actin–binding proteins is currently un-
known, but ponsin may independently regulate the func-
tion of each protein, or may regulate the linkage between
l-afadin and vinculin in cooperation with another still uni-
dentified factor. If the latter is the case, l-afadin may be lo-
calized at ZA in epithelial cells and at cell–cell AJ in non-
epithelial cells by interacting with the cadherin-catenin
system through the ponsin-vinculin system (Fig. 13).
ZO and ZA in the junctional complex of polarized epi-
thelial cells are closely aligned from the apical side to the
basal side, suggesting that these two junction structures
have their molecular interactions. ZO is also linked to the
Figure 12. Localization of
ponsin, E-cadherin, and vin-
culin in various rat tissues.
(A) The double staining of
small intestine absorptive ep-
ithelial cells with the anti-
ponsin and anti–E-cadherin
antibodies. (A1) Ponsin and
(A2) E-cadherin. *Apical
side. (B) The double staining
of heart with the anti-ponsin
and anti-vinculin antibodies.
(B1) Ponsin and (B2) vincu-
lin. (Arrow) Intercalated disc
and (arrowhead) costamere.
(C) The staining of liver with
the anti-ponsin antibody. (D)
Ultrastructural localization
of ponsin in small intestine
absorptive epithelial cells.
Intestine absorptive epithe-
lial cells were labeled with
the anti-ponsin antibody.
(Open arrow) ZO, (closed
arrow) ZA, and (open ar-
rowhead) desmosome. Bars:
(A and C) 10, (B) 50, and
(D) 0.1 mm. The results are
representative of three inde-
pendent experiments.Mandai et al. Ponsin: An l-AfadinÐ and Vinculin-binding Protein 1015
actin cytoskeleton. At ZO, multiple integral membrane
proteins with four transmembrane regions, the claudin
family members and occludin, constitute tight junction
strands (Furuse et al., 1993, 1998; Ando-Akatsuka et al.,
1996). The cytoplasmic region of occludin binds ZO-1 (Fu-
ruse et al., 1994), which interacts with F-actin (Itoh et al.,
1997). The cytoplasmic regions of the claudin family mem-
bers may also directly or indirectly bind ZO-1 (Furuse et al.,
1998). Evidence is accumulating that the cadherin-catenin
system plays essential roles for the assembly of the junc-
tional complex (Gumbiner and Simons, 1986; Gumbiner
et al., 1988; Watabe et al., 1994). It has recently been
shown by use of an a-catenin–deficient colon carcinoma
cell line that the binding of vinculin to a-catenin is re-
quired for the organization of ZO (Watabe-Uchida et al.,
1998). It has furthermore been shown that the junctional
organization is impaired in vinculin-null F9 cells (Watabe-
Uchida et al., 1998). It should be noted from the present
and previous (Mandai et al., 1997) results that l-afadin and
ponsin as well as vinculin are more highly concentrated at
ZA than cadherin. The afadin-ponsin system may be in-
volved in the assembly of the junctional complex by inter-
acting with vinculin.
We recently found that l-afadin and E-cadherin showed
different behavior during the formation and destruction of
cell–cell AJ in MDCK and L cells (Sakisaka et al., 1999).
Dissociation of MDCK cells by culturing the cells at 2 mM
Ca21 caused rapid endocytosis of E-cadherin, but not that
of l-afadin or ZO-1. Addition of phorbol 12-myristate 13-
acetate to these dissociated cells formed a ZO-like struc-
ture where ZO-1 and l-afadin, but not E-cadherin, accu-
mulated. Even in cadherin-deficient L cells, l-afadin was
mainly localized at cell–cell contacts, whereas ZO-1 was
mainly localized at the tip area of cell processes. l-Afadin
did not directly bind to a-, b-catenin, E-cadherin, ZO-1, or
occludin. All of the results thus far available suggest that
there is an integral membrane protein that is specifically
localized at ZA in epithelial cells and at cell–cell AJ in
nonepithelial cells and interacts with the afadin–ponsin–
vinculin system (Fig. 13). It would be of crucial importance
to identify this protein for our understanding of the physi-
ological significance of l-afadin and ponsin.
Ponsin-1 and -2 were splicing variants of SH3P12.
SH3P12 was suddenly renamed CAP in the GenBank da-
tabase during the revision of this manuscript. CAP was
originally isolated as a c-Cbl–binding protein (Ribon et al.,
1998a). c-Cbl is a proto-oncogene product involved in T
cell antigen receptor–mediated signaling (Thien and Lang-
don, 1998). In this CAP paper, no nucleotide or amino
acid sequence information was available. Homology
searches of DNA and protein databases furthermore re-
vealed another protein structurally related to ponsin/
SH3P12, ArgBP2. ArgBP2 was isolated as an Arg- and
Abl-binding protein (Wang et al., 1997). Arg and Abl rep-
resent the members of the Aberson family of tyrosine ki-
nase. During the revision of this manuscript, Kioka et al.
(1999) isolated a protein structurally related to ponsin/
SH3P12, named vinexin, as a vinculin-binding protein. All
of these proteins have three SH3 domains and one or two
sorbin-like regions. These results suggest that ponsin/
SH3P12/CAP, ArgBP2, and vinexin constitute a family.
Structural comparison of these proteins suggest that pon-
sin/SH3P12/CAP, ArgBP2, and vinexin are derived from
three different genes and constitute three subfamilies.
Vinexin as well as ponsin/SH3P12 is localized at both cell–
cell and cell–matrix AJs (Kioka et al., 1999), whereas both
SH3P12/CAP and ArgBP2 are associated with actin stress
fibers (Wang et al., 1997; Ribon et al., 1998b). Vinexin
enhances the actin cytoskeleton reorganization and cell
spreading (Kioka et al., 1999). SH3P12/CAP enhances ac-
tin stress fiber formation and focal adhesions and is associ-
ated with signaling molecules such as the insulin receptor,
focal adhesion kinase (FAK), and SOS, a Ras small G pro-
tein exchanger (Ribon et al., 1998a,b). Thus, the members
of the family that has three SH3 domains and one or two
sorbin-like regions show similar and different subcellular
localization and association with other proteins, suggesting
their related but diverse functions.
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